STING agonist-20
STING agonist-20 (compound 95) is a potent STING agonist used in the synthesis of XMT-2056. STING agonist-20 can be used as a vaccine adjuvant in the study of cancer and other inflammatory, immune diseases[1].
Product Specifications
CAS Number
[2591300-72-8]
UNSPSC
12352005
Target
STING
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/sting-agonist-20.html
Concentration
10mM
Purity
99.79
Solubility
DMSO : 80 mg/mL (ultrasonic)
Smiles
O=C(C1=C(N=C(O1)C)CC)NC2=NC3=CC(C(N)=O)=CN=C3N2C/C=C/CN4C5=C(OCCCO)C=C(C(N)=O)C=C5N=C4NC(C6=C(N=C(O6)C)CC)=O
Molecular Formula
C36H39N11O8
Molecular Weight
753.76
References & Citations
[1]R. DUVALL J, et al., Sting agonist compounds and methods of use. US20210032269
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human SGO1 sgRNA gene knockout kit - Lentiviral human SGO1 sgRNA gene knockout kit (plasmid)
SPP1 (Secreted Phosphoprotein 1, BNSP, BSPI, ETA-1, MGC110940, OPN) (AP) discontinued
STAG2 (Stromal Antigen 2, SA2, SA-2, Cohesin Subunit SA-2, SCC3 Homolog 2, SCC3B, bA517O1.1) (FITC)
STAG2 (Stromal Antigen 2, SA2, SA-2, Cohesin Subunit SA-2, SCC3 Homolog 2, SCC3B, bA517O1.1) (FITC)
